DrugCentral 2023 ๐
2022 Update-Veterinary Drugs & Uses
Search
Structure ๐
Similarity ๐
Smart API
Redial
About
Download
L1000
FAQ
DrugCentral 2023 ๐
2022 Update-Veterinary Drugs & Uses
Search
Structure ๐
Similarity ๐
Smart API
Redial
About
Download
L1000
FAQ
Scroll
All
FDA-approved
EMA-approved
PMDA-approved
Target Card Uniprot Example:
P23975
bumetanide ๐ถ
Veterinary Use |
Indications/Contra
| FAERs-F
| FAERs-M
| Orange Bk
| BioActivity |
Stem definition
Drug id
CAS RN
diuretics, piretanide derivatives
427
28395-03-1
Description:
Molecule
Description
Molfile
Inchi
Smiles
Synonyms:
bumetanide
bumethanide
bufenox
A sulfamyl diuretic.
Molecular weight: 364.42
Formula: C17H20N2O5S
CLOGP: 3.07
LIPINSKI: 0
HAC: 7
HDO: 3
TPSA: 118.72
ALOGS: -4.15
ROTB: 8
Status: OFP
Legend:
OFP - off patent
OFM - off market
ONP - on patent
Drug dosage:
Dose
Unit
Route
1
mg
O
1
mg
P
1
mg
O
ADMET properties:
Show
10
25
50
100
entries
Search:
Property
Value
Reference
BA (Bioavailability)
90 %
Kim MT, Sedykh A, Chakravarti SK, Saiakhov RD, Zhu H
EoM (Fraction excreted unchanged in urine)
45 %
Benet LZ, Broccatelli F, Oprea TI
BDDCS (Biopharmaceutical Drug Disposition Classification System)
3
Benet LZ, Broccatelli F, Oprea TI
CL (Clearance)
2.50 mL/min/kg
Lombardo F, Berellini G, Obach RS
t_half (Half-life)
1.20 hours
Lombardo F, Berellini G, Obach RS
MRTD (Maximum Recommended Therapeutic Daily Dose)
0.46 ยตM/kg/day
Contrera JF, Matthews EJ, Kruhlak NL, Benz RD
Vd (Volume of distribution)
0.16 L/kg
Lombardo F, Berellini G, Obach RS
S (Water solubility)
0.10 mg/mL
Benet LZ, Broccatelli F, Oprea TI
fu (Fraction unbound in plasma)
0.03 %
Lombardo F, Berellini G, Obach RS
Showing 1 to 9 of 9 entries
Previous
1
Next
Approvals:
Show
10
25
50
100
entries
Search:
Date
Agency
Company
Orphan
Feb. 28, 1983
FDA
Showing 1 to 1 of 1 entries
Previous
1
Next
FDA Adverse Event Reporting System (Female)
Show
10
25
50
100
entries
Search:
MedDRA adverse event term
Likelihood ratio
Likelihood ratio threshold
Patients taking drug having adverse event
Patients taking drug not having adverse event
Patients not taking drug having adverse event
Patients not taking drug not having adverse event
Acute kidney injury
247.13
13.45
429
27771
262986
63197836
Cardiac failure congestive
238.04
13.45
247
27953
92186
63368636
Hypervolaemia
200.21
13.45
136
28064
28277
63432545
Fluid retention
199.43
13.45
184
28016
59502
63401320
Dyspnoea
180.44
13.45
672
27528
660641
62800181
Pulmonary arterial hypertension
137.85
13.45
99
28101
22478
63438344
Right ventricular failure
134.88
13.45
88
28112
17100
63443722
Body tinea
131.19
13.45
44
28156
1841
63458981
Pulmonary hypertension
125.02
13.45
115
28085
37008
63423814
Inhibitory drug interaction
109.91
13.45
43
28157
2806
63458016
Showing 1 to 10 of 162 entries
Previous
1
2
3
4
5
โฆ
17
Next
FDA Adverse Event Reporting System (Male)
Show
10
25
50
100
entries
Search:
MedDRA adverse event term
Likelihood ratio
Likelihood ratio threshold
Patients taking drug having adverse event
Patients taking drug not having adverse event
Patients not taking drug having adverse event
Patients not taking drug not having adverse event
Acute kidney injury
257.90
13.15
575
21052
304413
34630891
Cardiac failure congestive
172.43
13.15
234
21393
83036
34852268
Cardiac failure
121.56
13.15
209
21418
91039
34844265
Dyspnoea
121.03
13.15
506
21121
376276
34559028
Fluid retention
116.53
13.15
111
21516
26776
34908528
Hypervolaemia
88.50
13.15
83
21544
19626
34915678
Pulmonary hypertension
88.03
13.15
85
21542
20839
34914465
Oedema peripheral
73.01
13.15
200
21427
119612
34815692
Drug ineffective
60.42
13.15
120
21507
456631
34478673
Pulmonary arterial hypertension
55.80
13.15
45
21582
8694
34926610
Showing 1 to 10 of 75 entries
Previous
1
2
3
4
5
โฆ
8
Next
FDA Adverse Event Reporting System (Geriatric)
Show
10
25
50
100
entries
Search:
MedDRA adverse event term
Likelihood ratio
Likelihood ratio threshold
Patients taking drug having adverse event
Patients taking drug not having adverse event
Patients not taking drug having adverse event
Patients not taking drug not having adverse event
Acute kidney injury
492.27
12.51
955
42655
518449
79182329
Cardiac failure congestive
356.87
12.51
414
43196
141988
79558790
Fluid retention
258.50
12.51
250
43360
69559
79631219
Hypervolaemia
242.59
12.51
195
43415
42495
79658283
Dyspnoea
241.47
12.51
1015
42595
856010
78844768
Cardiac failure
184.11
12.51
315
43295
154527
79546251
Pulmonary hypertension
175.70
12.51
171
43439
47909
79652869
Pulmonary arterial hypertension
166.30
12.51
132
43478
28234
79672544
Right ventricular failure
161.08
12.51
120
43490
23377
79677401
Oedema peripheral
142.62
12.51
379
43231
251909
79448869
Showing 1 to 10 of 209 entries
Previous
1
2
3
4
5
โฆ
21
Next
FDA Adverse Event Reporting System (Pediatric)
None
Pharmacologic Action:
Show
10
25
50
100
entries
Search:
Source
Code
Description
ATC
C03CA02
CARDIOVASCULAR SYSTEM
DIURETICS
HIGH-CEILING DIURETICS
Sulfonamides, plain
ATC
C03CB02
CARDIOVASCULAR SYSTEM
DIURETICS
HIGH-CEILING DIURETICS
Sulfonamides and potassium in combination
ATC
C03EB02
CARDIOVASCULAR SYSTEM
DIURETICS
DIURETICS AND POTASSIUM-SPARING AGENTS IN COMBINATION
High-ceiling diuretics and potassium-sparing agents
CHEBI has role
CHEBI:35498
diuretics
CHEBI has role
CHEBI:131770
CFTR inhibitors
FDA EPC
N0000175590
Loop Diuretic
FDA PE
N0000175366
Increased Diuresis at Loop of Henle
MeSH PA
D004232
Diuretics
MeSH PA
D049990
Membrane Transport Modulators
MeSH PA
D045283
Natriuretic Agents
Showing 1 to 10 of 11 entries
Previous
1
2
Next
Drug Use
| Suggest Off label Use Form|
|View source of the data|
Show
10
25
50
100
entries
Search:
Disease
Relation
SNOMED_ID
DOID
Edema
indication
267038008
Edema due to Hepatic Cirrhosis
indication
Peripheral Edema due to Chronic Heart Failure
indication
Renal Disease with Edema
indication
Pulmonary Edema due to Chronic Heart Failure
indication
Hypertensive disorder
off-label use
38341003
DOID:10763
Hypercalcemia
off-label use
66931009
DOID:12678
Decompensated cardiac failure
off-label use
195111005
Anuria
contraindication
2472002
DOID:2983
Hypocalcemia
contraindication
5291005
Showing 1 to 10 of 20 entries
Previous
1
2
Next
๐ถ Veterinary Drug Use
None
๐ถ Veterinary products
None
Acid dissociation constants calculated using MoKa v3.0.0
Show
10
25
50
100
entries
Search:
Dissociation level
Dissociation constant
Type (acidic/basic)
pKa1
4.36
acidic
pKa2
9.88
acidic
pKa3
0.86
Basic
Showing 1 to 3 of 3 entries
Previous
1
Next
Orange Book patent data (new drug applications)
None
Orange Book exclusivity data (new drug applications)
None
Bioactivity Summary:
Show
10
25
50
100
entries
Search:
Target
Class
Pharos
UniProt
Action
Type
Activity value
(-log[M])
Mechanism
action
Bioact source
MoA source
Solute carrier family 12 member 1
Transporter
Q13621
S12A1_HUMAN
INHIBITOR
Ki
7.60
WOMBAT-PK
CHEMBL
Sodium/potassium-transporting ATPase subunit alpha-1
Transporter
P05023
AT1A1_HUMAN
Kd
7.52
WOMBAT-PK
Solute carrier family 12 member 2
Transporter
P55011
S12A2_HUMAN
INHIBITOR
IC50
5.60
IUPHAR
G-protein coupled receptor 35
GPCR
Q9HC97
GPR35_HUMAN
AGONIST
EC50
5.54
IUPHAR
Showing 1 to 4 of 4 entries
Previous
1
Next
External reference:
Show
10
25
50
100
entries
Search:
ID
Source
002312
NDDF
0Y2S3XUQ5H
UNII
1808
RXNORM
2471
PUBCHEM_CID
2943
INN_ID
3606
MMSL
387498005
SNOMEDCT_US
4017794
VUID
4017794
VANDF
4304
MMSL
Showing 1 to 10 of 21 entries
Previous
1
2
3
Next
Pharmaceutical products:
Show
10
25
50
100
entries
Search:
Product
Category
Ingredients
NDC
Form
Quantity
Route
Marketing
Label
Bumetanide
HUMAN PRESCRIPTION DRUG LABEL
1
0185-0128
TABLET
0.50 mg
ORAL
ANDA
21 sections
Bumetanide
HUMAN PRESCRIPTION DRUG LABEL
1
0185-0128
TABLET
0.50 mg
ORAL
ANDA
21 sections
Bumetanide
HUMAN PRESCRIPTION DRUG LABEL
1
0185-0129
TABLET
1 mg
ORAL
ANDA
21 sections
Bumetanide
HUMAN PRESCRIPTION DRUG LABEL
1
0185-0129
TABLET
1 mg
ORAL
ANDA
21 sections
Bumetanide
HUMAN PRESCRIPTION DRUG LABEL
1
0185-0130
TABLET
2 mg
ORAL
ANDA
21 sections
Bumetanide
HUMAN PRESCRIPTION DRUG LABEL
1
0185-0130
TABLET
2 mg
ORAL
ANDA
21 sections
Bumetanide
HUMAN PRESCRIPTION DRUG LABEL
1
0409-1412
INJECTION, SOLUTION
0.25 mg
INTRAMUSCULAR
ANDA
20 sections
bumetanide
HUMAN PRESCRIPTION DRUG LABEL
1
0615-8361
TABLET
1 mg
ORAL
ANDA
20 sections
bumetanide
HUMAN PRESCRIPTION DRUG LABEL
1
0615-8362
TABLET
2 mg
ORAL
ANDA
20 sections
Bumetanide
HUMAN PRESCRIPTION DRUG LABEL
1
0615-8393
TABLET
1 mg
ORAL
ANDA
21 sections
Showing 1 to 10 of 30 entries
Previous
1
2
3
Next
Search
Structure ๐
Similarity ๐
Smart API
Redial
About
Download
L1000
FAQ
bumetanide